Viraferonpeg and aspartate aminotransferase increased 
Viraferonpeg and aspartate aminotransferase increased Patient Reports February 11, 2012
Viraferonpeg Side Effects Report #5988881-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Dec 01, 2008. Female patient, 74 years of age, weighting 160.9 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dysstasia, fatigue, haemoglobin decreased, paralysis , vomiting. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.Viraferonpeg Side Effects Report #6059457-5
Viraferonpeg side effect was reported by a Physician from FRANCE on Jan 23, 2009. Female patient, 68 years of age, weighting 112.4 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased. Viraferonpeg dosage: unknown. During the same period patient was treated with COTRIATEC, HEPTAMYL, ZOLPIDEM, NAFTIDROFURYL, PRAZEPAM. Patient recovered.Viraferonpeg Side Effects Report #6111174-9
Viraferonpeg side effect was reported by a Physician from FRANCE on Mar 04, 2009. Female patient, 68 years of age, weighting 112.4 lb, was diagnosed with hepatitis c
, feeling cold and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased. Viraferonpeg dosage: unknown. During the same period patient was treated with NAFTIDROFURYL, COTRIATEC, HEPTAMYL, ZOLPIDEM, LYSANXIA. Patient recovered.Viraferonpeg Side Effects Report #6125216-8
Viraferonpeg side effect was reported by a Physician from FRANCE on Mar 06, 2009. Female patient, 68 years of age, weighting 112.4 lb, was diagnosed with hepatitis c
, peripheral coldness and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased. Viraferonpeg dosage: unknown. During the same period patient was treated with NAFTIDROFURYL. Patient recovered.Viraferonpeg Side Effects Report #4995827-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Apr 24, 2006. Male patient, 44 years of age, weighting 123.5 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, hepatic cirrhosis, hyperbilirubinaemia, lipase increased, lobar pneumonia, pancreatitis, renal failure. Viraferonpeg dosage: unknown. During the same period patient was treated with DAPSONE, SUSTIVA, COMBIVIR, LAMIVUDINE, ZELITREX, ALDACTONE. Patient was hospitalized. Patient recovered.Viraferonpeg Side Effects Report #4781106-4
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 15, 2005. Male patient, 42 years of age, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient recovered.Viraferonpeg Side Effects Report #5345711-9
Viraferonpeg side effect was reported by a Physician from FRANCE on May 21, 2007. Male patient, 35 years of age, weighting 149.9 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: agitation, aspartate aminotransferase increased, bacterial infection , blood alkaline phosphatase increased, cd4 lymphocytes decreased, cerebral haematoma, cerebral haemorrhage, confusional state, disorientation. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, BACTRIMTE. Patient was hospitalized. Patient recovered.Viraferonpeg Side Effects Report #5574107-X
Viraferonpeg side effect was reported by a Physician from FRANCE on Dec 17, 2007. Female patient, 64 years of age, was diagnosed with hepatic cirrhosis, viral infection
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, blood bilirubin increased, prothrombin level decreased, thrombocytopenia. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient recovered.